 DUBLIN, Ireland, and Boston MA, July 21 , 202 2 , Amryt Nasdaq: AMYT a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that its unaudited financial results for the second quarter 2022 will be released on Thursday , August 4 , 202 2 at 0700 E T1200 BST. 